Differentiated thyroid cancer
Showing 1 - 25 of >10,000
Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)
Recruiting
- Differentiated Thyroid Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 9, 2023
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)
Not yet recruiting
- Differentiated Thyroid Cancer
- +3 more
- Larotrectinib monotherapy
- 131I therapy
- (no location specified)
Mar 13, 2023
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride
Not yet recruiting
- Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
- Anlotinib Hydrochloride Capsule and Penpulimab
-
Beijing, Beijing, ChinaYansongLin
Sep 25, 2023
Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)
Recruiting
- Thyroid Cancer
- Traditional neck dissection approach
- Anterior neck dissection approach
-
Medellin, Antioquia, ColombiaHospital Alma Mater de Antioquia
Nov 20, 2023
Efficacy of Lenvatinib in Differentiated Thyroid Cancer
Recruiting
- Differentiated Thyroid Cancer
- Gender
-
Rome, ItalyRegina Elena National Cancer Institute
Mar 16, 2023
Differentiated Thyroid Cancer Trial in China (AL2846 capsule)
Recruiting
- Differentiated Thyroid Cancer
- AL2846 capsule
-
Guilin, Guangxi, China
- +3 more
Feb 27, 2023
Quality of Life in Differentiated Thyroid Carcinoma Undergoing
Not yet recruiting
- Thyroid Cancer
- minimally invasive procedure
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hopsital
Sep 13, 2023
Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,
Recruiting
- Thyroid Cancer
- Thyrogen
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Differentiated Thyroid Cancer Trial in Beijing (Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH), radioactive
Recruiting
- Differentiated Thyroid Cancer
- Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH)
- radioactive iodine
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 28, 2022
Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri
May 5, 2023
18F-TFB PET/CT Scan in Differentiated Thyroid Cancer
Recruiting
- Differentiated Thyroid Gland Carcinoma
- +2 more
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Differentiated Thyroid Cancer Trial in Spain (Cabozantinib)
Not yet recruiting
- Differentiated Thyroid Cancer
-
Oviedo, Asturias, Spain
- +9 more
Dec 14, 2022
Differentiated Thyroid Cancer Trial (Low iodine diet)
Not yet recruiting
- Differentiated Thyroid Cancer
- Low iodine diet
- (no location specified)
Oct 25, 2022
Thyroid Tumor Follicular, Bone Metastases Trial in Beijing (Sr-89)
Not yet recruiting
- Thyroid Neoplasm Follicular
- Bone Metastases
-
Beijing, ChinaPeking Union Medical College Hospital
Jul 18, 2022
Differentiated Thyroid Cancer, Thyroid Cancer, Nonmedullary Trial in La Roche-sur-Yon, Nantes (WGS)
Recruiting
- Differentiated Thyroid Cancer
- Thyroid Cancer, Nonmedullary
- WGS
-
La Roche-sur-Yon, France
- +1 more
Feb 25, 2022
Thyroid Cancer Trial in Washington (99mTc sestamibi)
Terminated
- Thyroid Cancer
- 99mTc sestamibi
-
Washington, District of ColumbiaWashington Hospital Center
Jul 5, 2022
Reminder System (TCARS) Study - A Pilot Study.
Not yet recruiting
- Low Risk Differentiated Thyroid Cancer
- Shared-care model
- (no location specified)
Aug 18, 2022
Thyroglobulin and Galectin-3 for Prognosis and Follow-up in
Recruiting
- Thyroid Cancer
- +2 more
-
Taipei, TaiwanChih-Yuan Wang, M.D
Oct 16, 2022
Thyroglobulin Point of Care Assay for Rapid Detection of
Recruiting
- Differentiated Thyroid Cancer
- Lymph Node Metastases
- Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
-
Ashkelon, Israel
- +2 more
Oct 25, 2022
Thyroid Cancer Trial in Suita (Targeted alpha therapy)
Recruiting
- Thyroid Cancer
- Targeted alpha therapy
-
Suita, JapanOsaka University Hospital
Mar 2, 2022
Radioactive Iodine-refractory Differentiated Thyroid Cancer Trial in Beijing (Camrelizumab combination with Apatinib)
Recruiting
- Radioactive Iodine-refractory Differentiated Thyroid Cancer
- Camrelizumab combination with Apatinib
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jan 18, 2022
DTC - Differentiated Thyroid Cancer Trial in Beijing (Anlotinib HCl)
Recruiting
- DTC - Differentiated Thyroid Cancer
- Anlotinib hydrochloride
-
Beijing, ChinaPeking Union Medical College Hospital
Jan 18, 2022